Clinical experiences with low-molecular weight heparins in pediatric patients

Thrombosis Research

Volumn 103, Issue 5, 2001, Pages 345-353

  Hofmann, Sigrun ^a   Knoefler, Ralf ^a   Lorenz, Norbert ^a   Siegert, Gabriele ^a   Wendisch, Joerg ^a   Mueller, Diane ^a   Taut Sack, Heike ^a   Dinger, Juergen ^a   Kabus, Maria ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Children; Low molecular weight heparins

Indexed keywords

ALTEPLASE; BLOOD CLOTTING FACTOR 10A INHIBITOR; ENOXAPARIN; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADOLESCENT; ADULT; ARTERY THROMBOSIS; ARTICLE; BLOOD VESSEL OCCLUSION; BODY WEIGHT; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; GASTROINTESTINAL HEMORRHAGE; HAIR LOSS; HEPARINIZATION; HUMAN; IMMOBILIZATION; INFANT; INJURY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; PROPHYLAXIS; RECANALIZATION; SHORT COURSE THERAPY; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT OUTCOME; VEIN THROMBOSIS;

ADOLESCENT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; ENOXAPARIN; FACTOR XA; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFANT; INFANT, NEWBORN; MALE; NADROPARIN; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; THROMBOLYTIC THERAPY; THROMBOSIS; TREATMENT OUTCOME;

EID: 0035449623     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00335-8     Document Type: Article

References (40)

1. Indications and drugs for anticoagulation therapy in children
2. The comparison of pharmacokinetics of a low molecular heparin in the newborn and adult pig
3. Simple coagulation prophylaxis using low-molecular heparin enoxaparin in pediatric hemodialysis
4. Prevention of vascular thromboses after renal transplantation using low molecular weight heparin
5. Comparison of the pharmacokinetic profiles of three low molecular mass heparins - Dalteparin, enoxaparin and nadroparin - Administered subcutaneously in healthy volunteers (doses for prevention of thromboembolism)
6. Low molecular weight heparins
7. Heparin sensitivity: Report of a case
8. Anticoagulation therapy in pediatric patients with sinovenous thrombosis: A cohort study
9. The use of low molecular weight heparin in pediatric patients: A prospective cohort study
10. Pharmacology of low-molecular weight heparins
11. Low molecular weight heparin: A critical analysis of clinical trials
12. Long-term anticoagulation of outpatients with adverse events to oral anticoagulants using low-molecular weight heparin
13. Prophylaxis of thromboembolism in general surgery: Comparison between standard heparin and fragmin
14. Prevention of hepatic artery thrombosis in pediatric liver transplantation
15. Low molecular weight heparin
16. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis
17. Heparins - Anionic polyelectrolyte drugs
18. Efficacy and safety of a low molecular weight heparin and standard unfractionated heparin in prophylaxis of postoperative venous thromboembolism. A European multicenter trial
19. Heparin as a cause of thrombus progression
20. Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding study
21. Heparin-induced thrombocytopenia in children
22. Experience with dalteparin in paediatrics
23. The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: A report on 48 cases
24. Routine heparin therapy inhibits adrenal aldosterone production
25. Thrombopénie sévère induite par l'héparine chez un nourrisson porteur d'une myocardite aigue
26. Heparin-induced thrombocytopenia in a child
27. A comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis
28. Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis
29. Pediatric heparin-induced thrombocytopenia: Management with Danaparoid (orgaran)
30. Erfolgreiche behandlung einer heparin-induzierten thrombozytopenie typ II im kindesalter mit rekombinantem hirudin
31. Anticoagulant effects of heparin in neonatal plasma
32. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis
33. Heparin-induced thrombocytopenia in the newborn
34. Antithrombotic therapy in children
35. Heparin therapy in pediatric patients
36. Low molecular weight heparin for anticoagulation during haemodialysis in children - A preliminary study
37. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
38. Thrombotic complications of heparin therapy including six cases of heparin-induced skin necrosis
39. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172
40. Derzeitiger stand der thromboembolie-prophylaxe nach chirurgischen eingriffen bei kindern und jugendlichen